This effect is achieved by inhibiting the expression of c-FLIP, highlighting the potential therapeutic significance of miR-382 in enhancing the responsiveness of HCC cells to γδ T cell-mediated immunotherapy [82]. The gene discussed is CFLAR; the disease is hepatocellular carcinoma.